{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Yang T"],"funding":["Fundamental Research Funds for the Central Universities","Natural Science Foundation of Yunnan Province (CN)","CAMS Innovation Engineering Project","Yunnan Important New Product Development Plan","PUMC Youth Fund"],"pagination":["206"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5659012"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(1)"],"pubmed_abstract":["Background
Enterovirus 71 (EV71) is one of the causative agents of hand, foot and mouth disease, which mostly affects infants and children and leads to severe neurological diseases. Vaccination offers the best option for disease control. We have screened the virus strain FY-23 K-B, which is used as an inactivated vaccine strain. An important issue in the development of vaccines is whether they provide cross protection against all other strains.Methods
We collected and identified 19 clinical EV71 isolates from mainland China, which all belong to the C4 genotype. We established growth curves of the strains in Vero cells, performed genetic analysis, and evaluated the cross protection efficacy through neutralizing assays using antisera from a rabbit, monkey and adult human immu"],"journal":["Virology journal"],"pubmed_title":["A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro."],"pmcid":["PMC5659012"],"funding_grant_id":["2016FB037","2016ZX350070","3332016114","CAMS-I2M-2016zdxm-20","2013FZ134","2015BC008"],"pubmed_authors":["Li H","Xie T","Ma S","Xie Z","Yue L","Luo F","Li Q","Long R","Zhang Y","He X","Yang R","Yang T","Song X","Meng H"],"additional_accession":[]},"is_claimable":false,"name":"A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro.","description":"Background
Enterovirus 71 (EV71) is one of the causative agents of hand, foot and mouth disease, which mostly affects infants and children and leads to severe neurological diseases. Vaccination offers the best option for disease control. We have screened the virus strain FY-23 K-B, which is used as an inactivated vaccine strain. An important issue in the development of vaccines is whether they provide cross protection against all other strains.Methods
We collected and identified 19 clinical EV71 isolates from mainland China, which all belong to the C4 genotype. We established growth curves of the strains in Vero cells, performed genetic analysis, and evaluated the cross protection efficacy through neutralizing assays using antisera from a rabbit, monkey and adult human immu","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Oct","modification":"2025-05-29T21:25:32.317Z","creation":"2019-03-27T03:00:08Z"},"accession":"S-EPMC5659012","cross_references":{"pubmed":["29073897"],"doi":["10.1186/s12985-017-0872-8"]}}